A group of older men treated with AbbVie’s AndroGel testosterone replacement therapy for a year had a 20 percent greater buildup of non-calcified plaque in their arteries than men who received a placebo gel, according to a study published in the Journal of the American Medical Association. The men – 138 in total – had a mean age of 71 as well as having cardiovascular risk factors. Half had severe atherosclerosis, a buildup of fats, cholesterol, and other substances in and on the artery walls, which can cause blockages that can lead to conditions such as coronary artery disease, chronic ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.